Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Slides:

Advertisements

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada Moshe Ben-Shoshan, MD, Daniel W. Harrington, MA,

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

What drives prescription patterns in pediatric asthma management?

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study Anna.

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Ann-Marie M. Schoos, MD, PhD, Jacob D

Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood Hywel Williams, PhDa,

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma Christine L.M. Joseph,

Is 9 more than 2 also in allergic airway inflammation?

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial Marko Kalliomäki, MD, PhD,

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study Anna.

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Children with allergic and nonallergic rhinitis have a similar risk of asthma Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,

Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease Elke Rodríguez, MSc, Hansjörg Baurecht, MSc, Esther.

Rising prevalence of asthma is sex-specific in a US farming population

Advancing asthma care: The glass is only half full!

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Katherine A. Vierk, MPH, Kathleen M. Koehler, PhD, MPH, Sara B

Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children Kevin R. Murphy, MD, Robert.

Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies.

Physician needs in health informatics: Just ask the docs

Elina Jerschow, MD, MSc, Robert Y. Lin, MD, MSc, Moira M

Peter M. Wolfgram, MD, David B. Allen, MD

United Nations Climate Change Conferences: COP21 a lost opportunity for asthma and allergies and preparing for COP22 Isabella Annesi-Maesano, MD, PhD,

Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? Ting Seng Tang, MBBS, Thomas.

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1– related disease in children Kumud K. Singh, PhD, Alexis Lieser, MD,

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Reply Journal of Allergy and Clinical Immunology

Jon Genuneit, MD, MSc Journal of Allergy and Clinical Immunology

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

What are the best outcome measurements for atopic eczema

Is eczema really on the increase worldwide?

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

Medication use in children with asthma in Finland from 1995 to 2006

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Geographic variability in childhood asthma prevalence in Chicago

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two Carsten Flohr,

One step forward, 2 steps back: The enigma of preschool wheeze

Erik J. Saude, MD, PhD, Christopher D

Martin Brasholt, MD, Florent Baty, PhD, Hans Bisgaard, MD, DMSci

Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States Jonathan I. Silverberg, MD, PhD, MPH, Marc.

Reply Journal of Allergy and Clinical Immunology

Atopic endotype in childhood

Macrolide antibiotics and asthma treatment

Asthma: The past, future, environment, and costs

Personal and parental nativity as risk factors for food sensitization

Caroline C. Horner, MD, MSCI, Courtney Dula, MS, Leonard B

Environmental factors and eosinophilic esophagitis

Increased risk of eczema but reduced risk of early wheezy disorder from exclusive breast-feeding in high-risk infants Charlotte Giwercman, MD, Liselotte.

Advances in pediatric asthma in 2007

Negative affect, medication adherence, and asthma control in children

Natural history of cow’s milk allergy

Primary prevention of asthma and allergy

Presentation transcript:

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O. Clayton, MSc, Colin F. Robertson, MD, M. Innes Asher, MBChB Journal of Allergy and Clinical Immunology Volume 124, Issue 6, Pages 1251-1258.e23 (December 2009) DOI: 10.1016/j.jaci.2009.10.009 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 World maps showing prevalence of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Blue squares indicate prevalence of less than 5%, green circles indicate prevalence of 5% to less than 10%, yellow diamonds indicate prevalence of 10% to less than 15%, and red stars indicate prevalence of 15% or more. Europe is shown in greater detail in the inset section. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Ranked prevalence plots of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Ranked prevalence plots of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Questions on eczema symptoms used in ISAAC Phase Three. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

World maps showing prevalence of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Blue squares indicate prevalence of less than 1%, green circles indicate prevalence of 1% to less than 1.5%, yellow diamonds indicate prevalence of 1.5% to less than 2%, and red stars indicate prevalence of 2% or more. Europe is shown in greater detail in the inset section. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Ranked prevalence plots of current symptoms of eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Regions are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Ranked prevalence plots of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Ranked prevalence plots of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Ranked prevalence plots of lifetime reported “eczema” for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Ranked prevalence plots of lifetime reported “eczema” for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Scatter plots illustrating prevalence by sex for current symptoms of eczema (A), current symptoms of severe eczema (B), and lifetime reported “eczema” (C) for the age group 6 to 7 years, and current symptoms of eczema (D), current symptoms of severe eczema (E), and lifetime reported “eczema” (F) for the age group 13 to 14 years. Each symbol represents a center. The line of equality is shown on each plot. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Scatter plots illustrating prevalence by sex for current symptoms of eczema (A), current symptoms of severe eczema (B), and lifetime reported “eczema” (C) for the age group 6 to 7 years, and current symptoms of eczema (D), current symptoms of severe eczema (E), and lifetime reported “eczema” (F) for the age group 13 to 14 years. Each symbol represents a center. The line of equality is shown on each plot. Journal of Allergy and Clinical Immunology 2009 124, 1251-1258.e23DOI: (10.1016/j.jaci.2009.10.009) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions